Beryl Drugs (BOM:524606) ROE % Adjusted to Book Value : -9.32% (As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Beryl Drugs ROE % Adjusted to Book Value?

Beryl Drugs's ROE % for the quarter that ended in Mar. 2024 was -15.56%. Beryl Drugs's PB Ratio for the quarter that ended in Mar. 2024 was 1.67. Beryl Drugs's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -9.32%.

Beryl Drugs ROE % Adjusted to Book Value Historical Data

The historical data trend for Beryl Drugs's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beryl Drugs ROE % Adjusted to Book Value Chart

Beryl Drugs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

2.63

7.33

-11.86

13.12

5.42

Beryl Drugs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															4.12	-	10.06	-	-9.32

Competitive Comparison of Beryl Drugs's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Beryl Drugs's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beryl Drugs's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beryl Drugs's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Beryl Drugs's ROE % Adjusted to Book Value falls into.

Beryl Drugs ROE % Adjusted to Book Value Calculation

Beryl Drugs's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	9.05%	/	1.67
	=	5.42%

Beryl Drugs's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-15.56%	/	1.67
	=	-9.32%

Beryl Drugs ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Beryl Drugs's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Beryl Drugs (BOM:524606) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beryl Drugs Ltd (BOM:524606) » Definitions » ROE % Adjusted to Book Value

Traded in Other Exchanges

N/A

Address

133, Kanchan Bagh, Ground Floor, Indore, MP, IND, 452001

Website

http://www.beryldrugs.com

Beryl Drugs Ltd is a pharmaceutical company principally engaged in the manufacturing and marketing of allopathic pharmaceutical preparations. It also provides contract manufacturing services and veterinary products. It offers manufacturing options for product requirements like small-volume injectables in liquid form, small-volume injectables in dry powder form, eye and ear drops, intravenous fluids in poly pack and glass bottles, and veterinary medicines. The company earns the majority of its revenue from the sale of Bulk Drugs.

Beryl Drugs (BOM:524606) Headlines

No Headlines